Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
HALO logo

HALO

NGS
Halozyme Therapeutics Inc.
HealthcareBiotechnology
Watchlists:
Last updated: Wednesday 16th July 2025
56.60
-1.05 (-1.82%)
Prev Close:57.65
Open:57.71
Bid:56.5
Ask:56.7
52 Week Range
42.01
70.51
Volume:2,544,488
Mkt Cap:6,974 M
Price Target
$65.09
+15.0%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
News
J.P. Morgan Reaffirms Their Hold Rating on Halozyme (HALO)
TipRanks Auto-Generated Intelligence Newsdesk15 hours ago

J.P. Morgan analyst Jessica Fye maintained a Hold rating on Halozyme today and set a price target of $60.00. The company...

NeutralLow Impact
Financials

Financial Statements

HALO - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Dec-15
Depreciation And Amortization71 M74 M43 M3 M3 M4 M-2 M-2 M-2 M-2 M
Gain On Sale Of PPE772000.0-1 M-5000.0
General And Administrative Expense154 M149 M144 M50 M46 M77 M-2 M-2 M-2 M-2 M
Gross Profit Margin (profit Margin After CGS)856 M637 M521 M362 M224 M150 M142 M285 M113 M106 M
Interest Expense Non Operating19 M17 M8 M20 M12 M18 M22 M20 M5 M
Misc Other Special Charges24 M16 M-2 M-20 M5 M7 M8 M3 M1 M
Net Income (loss)444 M282 M202 M403 M129 M-72 M-80 M63 M-103 M-32 M
Net Income Common Stockholders444 M282 M202 M403 M129 M-72 M-80 M63 M-103 M-32 M
Net Income Continuous Operations444 M282 M202 M403 M129 M-72 M-80 M63 M-103 M-32 M
Net Non Operating Interest Income Expense-19 M-17 M-8 M-20 M-12 M-18 M-22 M-20 M-5 M
Normalized Income552 M275 M205 M
Operating Income551 M338 M268 M276 M144 M-68 M-69 M81 M-83 M-27 M
Operating Income Before Depreciation (EBITDA)646 M441 M323 M259 M153 M-57 M-61 M87 M-76 M-23 M
Operating Expense304 M299 M253 M86 M80 M218 M211 M204 M197 M133 M
Other Gand A154 M149 M144 M50 M46 M77 M-2 M-2 M-2 M-2 M
Other Impairment Of Capital Assets577000.01 M
Other Operating Expenses-612000.0-791000.0-787000.0-1 M-60 M-64 M-62 M-5 M
Rent And Landing Fees2 M3 M-2 M-2 M-2 M-2 M
Research Expense79 M76 M67 M36 M34 M141 M150 M151 M151 M93 M
Restructring And Mn A Income-1 M
Salaries And Wages43 M37 M24 M-36 M-31 M-26 M-21 M
Selling And Marketing Expense61 M54 M46 M40 M
Selling Expense61 M54 M46 M40 M
Total Income Available For Interest Expense (EBIT)557 M348 M266 M256 M150 M-61 M-62 M84 M-82 M-27 M
Total Revenues1,015 M829 M660 M443 M268 M196 M152 M317 M147 M135 M
Total Expenses464 M492 M393 M167 M123 M264 M201 M173 M163 M104 M
Total Revenue1,015 M829 M660 M443 M268 M196 M152 M50 M53 M46 M
Amord71 M74 M43 M4 M14 M2 M-2 M
Avgshs127 M132 M137 M141 M136 M289 M287 M136 M128 M127 M
Avgshsdt129 M134 M141 M147 M141 M144 M144 M139 M128 M129 M
Basiceps3.52.131.482.860.95-0.5-0.010.46-0.810.03
Basicepscont3.52.131.482.860.95-0.5
Cor159 M192 M139 M81 M43 M46 M-10 M-31 M-33 M-29 M
Depamor10 M11 M7 M3 M3 M4 M-2 M-2 M-2 M-2 M
Dileps3.432.11.442.740.91-0.5-1.120.45-0.81-0.25
Dilepscont3.432.11.442.740.91-0.5
Netincdisc444 M282 M202 M403 M129 M-72 M-80 M63 M-103 M-32 M
Othincexp-24 M-16 M-2 M20 M-5 M-7 M-8 M-3 M-1 M
Pretaxinc557 M348 M249 M249 M129 M-72 M-80 M62 M-102 M-32 M
Resdev79 M76 M67 M36 M34 M141 M150 M151 M151 M93 M
Restruct-1 M
Sga154 M149 M144 M50 M46 M77 M61 M54 M46 M40 M
Shsout246 M127 M135 M138 M135 M138 M145 M143 M130 M129 M
Specincchg1 M
Taxprov113 M67 M47 M-154 M217000.0-11000.0537000.0-1 M1 M-6 M
Top MarketXLS Rank stocks
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader